nicorandil has been researched along with Chronic Kidney Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Atighi, E; Babapour, B; Hosseninia, S; Mohammadi Kebar, S | 1 |
| Abdel Malek, H; Dahab, G; El Nashar, E; Eldosoky, M; Elshafey, M; Hussein, AM | 1 |
| Fan, Z; Ji, H; Jian, X; Li, Y | 1 |
| Kurian, GA; Ramesh, A; Ravindran, S; Swaminathan, K | 1 |
| Hashimoto, T; Iwamoto, N; Kobayashi, H; Nishida, M; Nishimura, M; Okamoto, Y; Okino, K; Ono, T; Sato, N; Takahashi, H; Tokoro, T; Yamazaki, S | 1 |
| Hashimoto, T; Kobayashi, H; Nishida, M; Nishimura, M; Okamoto, Y; Ono, T; Sato, N; Takatani, T; Yamazaki, S | 1 |
| Higaki, M; Johnson, RJ; Nagura, M; Nakagawa, T; Shima, T; Shiraishi, T; Tamura, Y; Taniguchi, K; Uchida, S; Ueda, S | 1 |
| Kawasaki, M; Kinomura, Y; Minatoguchi, S; Nawa, T; Nishigaki, K; Tanaka, T; Yamada, Y | 1 |
| Abe, T; Goto, K; Hidaka, S; Noguchi, T; Ohchi, Y; Shitomi, R; Yamamoto, S; Yasuda, N | 1 |
5 trial(s) available for nicorandil and Chronic Kidney Diseases
| Article | Year |
|---|---|
Preventive Effects of Nicorandil and Atorvastatin in Contrastinduced Nephropathy in Patients with Renal Dysfunction Undergoing Coronary Artery Angiography: A Double Blind, Randomized, Controlled Clinical Trial.
Topics: Atorvastatin; Coronary Angiography; Coronary Vessels; Humans; Nicorandil; Renal Insufficiency; Renal Insufficiency, Chronic | 2023 |
Efficacy of Oral Nicorandil to Prevent Contrast-Induced Nephropathy in Patients with Chronic Renal Dysfunction Undergoing an Elective Coronary Procedure.
Topics: Aged; Cardiac Surgical Procedures; Contrast Media; Coronary Angiography; Creatinine; Cystatin C; Elective Surgical Procedures; Female; Glomerular Filtration Rate; Humans; Hypodermoclysis; Kidney Diseases; Male; Middle Aged; Nicorandil; Renal Insufficiency, Chronic | 2019 |
Clinical potential of oral nicorandil to improve myocardial fatty acid metabolism after percutaneous coronary intervention in hemodialysis patients.
Topics: Aged; Coronary Artery Disease; Death, Sudden, Cardiac; Fatty Acids; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardium; Nicorandil; Percutaneous Coronary Intervention; Renal Dialysis; Renal Insufficiency, Chronic; Survival Rate; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2014 |
Improvement of myocardial fatty acid metabolism by oral nicorandil in hemodialysis patients without coronary artery disease.
Topics: Administration, Oral; Aged; Cardiovascular Diseases; Coronary Artery Disease; Disease-Free Survival; Fatty Acids; Female; Heart; Humans; Iodobenzenes; Male; Middle Aged; Myocardium; Nicorandil; Renal Dialysis; Renal Insufficiency, Chronic; Serum Albumin; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2015 |
Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Cystatin C; Female; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Kidney Function Tests; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Perioperative Care; Postoperative Complications; Protective Agents; Regression Analysis; Renal Insufficiency, Chronic; Treatment Outcome | 2015 |
4 other study(ies) available for nicorandil and Chronic Kidney Diseases
| Article | Year |
|---|---|
Effects of nicorandil on vascular and renal dysfunctions in adenine-induced nephropathy: Possible underlying mechanisms.
Topics: Adenine; Animals; Kidney; Male; Nicorandil; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic | 2019 |
Nicorandil attenuates neuronal mitochondrial dysfunction and oxidative stress associated with murine model of vascular calcification.
Topics: Animals; Aorta; Calcium; Catalase; Drug Administration Schedule; Free Radical Scavengers; Histocompatibility Antigens Class I; Kidney Function Tests; Lipid Peroxidation; Mitochondria; Mitochondrial Diseases; Nicorandil; Oxidative Stress; Phosphorus; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Thiobarbituric Acid Reactive Substances; Vascular Calcification; Vitamin B Complex | 2017 |
Combination of ACE inhibitor with nicorandil provides further protection in chronic kidney disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Blood Pressure; Cell Line; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enalapril; KATP Channels; Kidney; Male; Mice; Nephrectomy; Nicorandil; Oxidative Stress; Podocytes; Potassium Channel Blockers; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Sirtuin 3; Sulfonylurea Receptors; Superoxide Dismutase; Time Factors | 2014 |
Should nicorandil infusion be adapted in dialysis-dependent patients undergoing continuous renal replacement therapy after cardiac surgery?
Topics: Aged; Aged, 80 and over; Cardiac Surgical Procedures; Drug Administration Schedule; Drug Monitoring; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Nicorandil; Renal Insufficiency, Chronic; Renal Replacement Therapy; Time Factors; Treatment Outcome; Vasodilator Agents | 2013 |